<DOC>
	<DOCNO>NCT02301065</DOCNO>
	<brief_summary>Viral infection reactivation pediatric allogeneic hematopoietic stem cell transplantation ( HSCT ) common occurrence significantly contribute post-transplant morbidity mortality . The risk high due prolong period immune deficiency await immune reconstitution post-transplant . Current strategy reduce complication viral infection include prophylactic treatment , close monitoring viral infection prompt treatment first sign symptom increase viral load . However , definitive treatment viral infection remain host 's cellular defense . Improved understanding immune system response viral infection may lead good treatment strategy . This study do explore relationship T-cells NK cell ( infection fight cell ) viral infection reactivations young allogeneic stem cell transplant patient . The investigator look cell react function young patient receive allogeneic stem cell transplantation , well healthy stem cell donor .</brief_summary>
	<brief_title>Analysis T Cell Natural Killer ( NK ) Cell Relation Viral Infections Pediatric Stem Cell Transplant Patients Donors</brief_title>
	<detailed_description>PRIMARY OBJECTIVE : - To explore expansion pattern KIR+CD56+ T-cells FcRg-CD56+CD3- NK cell response viral infection reactivation pediatric allogeneic hematopoietic stem cell transplant ( HSCT ) patient . SECONDARY OBJECTIVES : - To describe phenotype KIR+CD56+ T-cells FcRg-CD56+CD3- NK cell pediatric allogeneic HSCT patient healthy donor . - To describe specificity functional capacity KIR+CD56+ T-cells viral antigen pediatric allogeneic HSCT patient healthy donor . - To describe functional capacity FcRg-CD56+CD3- NK cell CMV-infected cell pediatric allogeneic HSCT patient healthy donor .</detailed_description>
	<criteria>Patients undergo allogeneic hematopoietic stem cell transplant ( HSCT ) hematologic malignancy donor patient undergo allogeneic hematopoietic stem cell transplant hematologic malignancy . For HSCT patient : age birth 21 year old ; donor : age . For minor le 18 year old , parent must available St. Jude campus provide consent . One parent/legal guardian acceptable one parent decease , incompetent , one parent present legal responsibility care custody child . Patients undergo allogeneic hematopoietic stem cell transplant disease hematologic malignancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Viral</keyword>
	<keyword>Infection</keyword>
	<keyword>Allogeneic Stem Cell Transplant</keyword>
</DOC>